ARALEZ PHARMACEUTICALS INC. Deferred Tax Assets, Valuation Allowance, Noncurrent
ARALEZ PHARMACEUTICALS INC. had Deferred Tax Assets, Valuation Allowance, Noncurrent of $64.14 million as of 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent · last filed 2018-03-14
- 2017-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $64.14M.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $50.71M.
- 2015-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $43.89M.
| Period end | Deferred Tax Assets, Valuation Allowance, Noncurrent |
|---|---|
| 2017-12-31 | $64.14M 10-K · filed 2018-03-14 |
| 2016-12-31 | $50.71M 10-K · filed 2018-03-14 |
| 2015-12-31 | $43.89M 10-K · filed 2017-03-13 |